Epidemiology of psychotropic medication use: Comparison of sales, prescriptions and survey data in Iceland

References

• Helgason T. Epidemiology of psychiatric disorders in Iceland. Nord J Psychiatry 1996; 50 Suppl 36: 31–8
   Web of Science ®Google Scholar
• Jenkins R, Lewis G, Bebbington P, Brugha T, Farrell M, Gill B, et al. The National Psychiatric Morbidity surveys of Great Britain—Initial findings from the household survey. Psychol Medicine 1997; 27: 775–89
   PubMed Web of Science ®Google Scholar
• Stordal E. Aspects of the epidemiology of depressions based on self-rating in a large general health study (The Hunt-2 study). National University for Science and Technology, Trondheim 2005
   Google Scholar
• Brugha T, Bebbington P, Singleton N, Melzer D, Jenkins R, Lewis G, et al. Trends in service use and treatment for mental disorders in adults throughout Great Britain. Br J Psychiatry 2004; 185: 378–84
   PubMed Web of Science ®Google Scholar
• Kessler R, Zhao S, Blazer D, Swartz M. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. J Affect Disord 1997; 45: 19–30
   PubMed Web of Science ®Google Scholar
• Lehtinen V, Lindholm T, Vejola J, Väsinänen E. The prevalence of PSE-Catego disorders in a adult Finnish cohort. Soc Psychiatry Psychiatr Epidemiol 1990; 25: 187–92
   PubMed Web of Science ®Google Scholar
• NOMESCO. Medicines consumption in the Nordic countries 1999–2003. Copenhagen: Nordic Medico Statistical Committee; 2004.
   Google Scholar
• NOMESCO. Health statistics in the Nordic countries. 2000. Copenhagen: Nordic Medico Statistical Committee; 2002.
   Google Scholar
• Sigfússon, E. Notkun lyfja á Íslandi 1989–1999 (Drug use in Iceland 1989–1999). Reykjavík: Heilbrigðis- og tryggingamálaráðuneytið; 2000.
   Google Scholar
• Helgason T, Tómasson K, Sigfússon E, Zoëga T. Skimun fyrir algengi geðraskana 1984 og 2002 og ávísanir geðlyfja 1984 og 2001 (Screening for mental disorders in the community 1984 and 2002 and prescriptions for psychopharmaca in 1984 and 2001. Læknablaðið 2004; 90: 553–9
   PubMedGoogle Scholar
• Verdoux H, Bégaud B. Pharmaco-epidemiology: What do (and don't) we know about utilisation and impact of psychotropic medications in real-life conditions?. Br J Psychiatry 2004; 185: 93–4
   PubMed Web of Science ®Google Scholar
• ATC. ATC Index with DDDs. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; Norwegian Institute of Public Health; 2002.
   Google Scholar
• Helgason T, Tómasson H, Zoëga T. Antidepressants and public health in Iceland. Time series analysis of national data. Br J Psychiatry 2004; 184: 157–63
   PubMed Web of Science ®Google Scholar
• Sigfússon, E. Notkun lyfja á Íslandi 1992–2001 (Drug use in Iceland 1992–2002). Reykjavík: Heilbrigðis- og tryggingamálaráðuneytið, , (Ministry of Health and Social Security); 2002.
   Google Scholar
• McCullagh P, Nelder J. Generalized linear models. Chapman and Hall, London 1989
   Google Scholar
• CSM. Committee on Safety of Medicines: Selective serotonin reuptake inhibitor (SSRI) antidepressants. Annex A—Prescribing trends for SSRIs and related antidepressants. 2004 [cited 2005; Available from:, , http//medicines.mhra.gov.uk/ourwork/monitorsafequalmed/safetymessage/Annex20%pdf]
   Google Scholar
• Helgason T, Björnsson J, Zoëga T, Þorsteinsson H, Tomasson H. Psychopharmacoepidemiology in Iceland: Effects of regulations and new medications. Eur Arch Psychiatry Clin Neurosci 1997; 247: 93–9
   PubMed Web of Science ®Google Scholar
• Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Patient adherence in the treatment of depression. Br J Psychiatry 2002; 180: 104–9
   PubMed Web of Science ®Google Scholar
• Cramer J, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv 1998; 49: 196–201
   PubMed Web of Science ®Google Scholar
• Melartin T, Rytsala H, Leskela U, Lestela-Mielonen P, Sokero T, Isometsa E. Continuity is the main challenge in treating major depressive disorder in psychiatric care. J Clin Psychiatry 2005; 66: 220–7
   PubMed Web of Science ®Google Scholar
• Seeman M. Gender differences in the prescribing of antipsychotic drugs. Am J Psychiatry 2003; 161: 1324–33
   Web of Science ®Google Scholar
• Helgason, T. Aðferðafræðilegur vandi við kannanir á áfengisneyslu. Samanburður á niðurstöðum póstkönnunar 1984 og símakönnunar 1985 (Methodological problems in studies of alcohol consumption. Comparison of results from a postal survey in 1984 and a telephone survey in 1985). Læknablaðið 1988;74:137–44.
   Google Scholar
• SUSY. Sundheds- og sygelighedsundersögelsen. 2000 (The Danish Health and Morbidy Survey 2000). 2001 [cited 2004; Available from:, , http://www.folkesundhed.dk/]
   Google Scholar
• Kessler R, Frank R, Edlund M, Katz S, Lin E, Leaf P. Differences in the use of psychiatric outpatient services between the United States and Ontario. New Eng J Med 1997; 8: 551–7
   Google Scholar